Cilates enzyme preparation - Cilian
Alternative Names: CEP - Cilian; CilaseLatest Information Update: 28 Aug 2020
At a glance
- Originator Cilian
- Class Enzymes
- Mechanism of Action Lipase replacements; Peptide hydrolase replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes - Exocrine pancreatic insufficiency
Highest Development Phases
- No development reported Exocrine pancreatic insufficiency
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for preclinical development in Exocrine-pancreatic-insufficiency in Germany (PO)
- 12 Jul 2016 Cilates enzyme preparation - Cilian is available for licensing as of 12 Jul 2016. http://www.cilian.com/
- 12 Jul 2016 Preclinical trials in Exocrine pancreatic insufficiency in Germany (PO)